A detailed history of Parallel Advisors, LLC transactions in Omeros Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,159 shares of OMER stock, worth $23,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,159
Previous 2,000 57.95%
Holding current value
$23,408
Previous $6,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$3.06 - $4.48 $3,546 - $5,192
1,159 Added 57.95%
3,159 $12,000
Q1 2025

Apr 07, 2025

BUY
$7.04 - $11.21 $14,080 - $22,420
2,000 New
2,000 $16,000
Q2 2020

Jul 16, 2020

SELL
$12.21 - $16.99 $1,623 - $2,259
-133 Closed
0 $0
Q1 2020

Apr 27, 2020

BUY
$9.03 - $19.72 $1,200 - $2,622
133 New
133 $1,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $465M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.